ArticleJournal of pain research2025
Dorsal Root Ganglion Pulsed Radiofrequency with Scar Radiofrequency Ablation Combined for Chronic Postoperative Abdominal Pain: A Retrospective Study.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pulsed Radiofrequency of the Sacral Dorsal Root Ganglia as a Potential Rescue Therapy for Refractory Chronic Pelvic Pain: A Case Series.The American journal of case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic postoperative abdominal pain (CPAP) manifests as neuropathic or mixed pain, and conservative treatments often only provide temporary relief. This study evaluated the efficacy and safety of combining dorsal root ganglion pulsed radiofrequency (DRG-PRF) with scar radiofrequency ablation (RFA) for a better treatment. Methods: A total of 48 CPAP patients were divided into the scar RFA group (RFA group, n = 25) and the combination of DRG-PRF and scar RFA group (RFA+PRF group, n = 23). The visual analogue scale (VAS) and Globe Pain Scale (GPS) questionnaires were used for pain intensity and its effects before and at intervals of 1, 7, 30, 90 and 180 days after the procedure. Results: Baseline scores were comparable. The RFA+PRF group demonstrated significantly lower VAS scores at 1-day (1.2 ± 1.0 vs 1.6 ± 1.1, Conclusion: The combination of DRG-PRF and scar RFA has demonstrated significant efficacy and high safety in the treatment of CPAP. Compared to scar RFA alone, the combined therapy provides more durable and significant long-term pain relief, making it a better choice for pain management in CPAP patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.